Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA
Written03-2015Jessica Johnston, Endre Kiss-Toth
Department of Cardiovascular Science, University of Sheffield, Sheffield, Beech Hill Road, Sheffield S10 2RX, United Kingdom

Abstract Review on TRIB1, with data on DNA, on the protein encoded, and where the gene is implicated.

Keywords TRIB1

(Note : for Links provided by Atlas : click)

Identity

Alias_namestribbles homolog 1 (Drosophila)
Alias_symbol (synonym)C8FW
GIG2
TRB1
Other aliasGIG-2
SKIP1
HGNC (Hugo) TRIB1
LocusID (NCBI) 10221
Atlas_Id 43539
Location 8q24.13; Transcript (including UTRs) chr8:126,442,563-126,450,644 Coding region: chr8:126,443,145-126,448,713.  [Link to chromosome band 8q24]
Location_base_pair Starts at 125432209 and ends at 125438405 bp from pter ( according to hg19-Feb_2009)  [Mapping TRIB1.png]
Note The tribbles family of genes encode a group of highly conserved pseudokinase proteins, which are thought to act as adaptors in several signalling pathways that are intimately involved in the regulation of a number of key cellular processes, including MAPK, and PI3K pathways. Tribbles have also been shown to interact with ubiquitin ligases, thereby promoting degradation of target proteins. Tribbles have been implicated in a number of diseases including leukaemia, metabolic syndromes and cardiovascular disease.
Tribbles proteins were first discovered in Drosophila as a negative regulator of string/cdc25, where when over-expressed directly inhibited mitosis (Grosshans and Wieschaus 2000). Simultaneously, TRIBs were found to promote the degradation of string via the proteasome pathway and showed that overexpression of tribbles in imaginal disc cells blocked the cell cycle at G2 resulting in abnormal wing morphology (Mata, et al 2000). Since then three highly conserved mammalian homologues have been indentified; Trib1, Trib2 and Trib3.

DNA/RNA

 
  There are two validated transcripts of TRIB1 (NM_025195 and NM_001282985) coding for isoforms 1 and 2 respectively. Isoform 2 has a shorter 5'UTR (untranslated region) and 5' coding region compared to isoform 1 and initiates translation further downstream. UTRs and exons are represented by the red and grey boxes respectively. Image drawn by FancyGene (Rambaldi and Ciccarelli 2009).
Transcription There are two protein coding transcripts of TRIB1; TRIB1-001 and TRIB1-002.
TRIB1-001 (Isoform 1); Transcript size: 3,635bp; Exon count: 3.
TRIB1-002 (Isoform 2); Transcript size: 1,332 bp; Exon count: 2

Protein

Note TRIB1-001: 372 amino acids; TRIB1-002: 206 amino acids
 
  Protein structure of Tribbles 1: TRIB1 has a N terminal, pseudokinase and C terminal domains. It contains four protein motifs; a putative PEST sequence, a kinase dead catalytic loop, a MEK1 binding and COP1 binding motif. The characteristic amino acid sequence for each motif is shown along with location.
Description TRIB1 contain a N terminal (NT) domain of 60-80 residues and a C-terminal domain of 35-40 residues and a characteristic single central Ser/Thr kinase-like (pseudokinase) domain. TRIB1 contains features consistent with its emerging role as a protein adaptor in signalling pathways.
N-Terminal Domain The NT fragment of TRIB1 is proline and serine rich, mostly in the sequence adjacent to the kinase-like domain. The abundance of these amino acids are a characteristic of PEST proteins that are involved in controlling the half life of proteins by altering their susceptibility to degradation. Other functions of these types of proteins include the anchoring of SH3 or WW domains of other proteins or acting as a substrate for proline dependent phosphorylation. TRIB1 contains possible phosphorylation sites for proline-dependent kinases (Hegedus, et al 2007).
TRIB1 also contains two evolutionary conserved motifs. The first consists of a putative nuclear localisation signal, [K/R]2X2[D/E]X[D/E]. The second motif contains a G-S-P consensus pattern found close to the kinase-like domain. The G-S-P motif is present in human SNIP1 (Smad nuclear interacting protein) which functionally associates with BGR1, which interacts with the Drosophila homologue of Slbo, C/EBP transcription factors (Beausoleil, et al 2004, Kadam, et al 2000). C/EBP transcription factors have been shown to functionally and physically interact with TRIB1 promoting their degradation (Yoshida, et al 2013).
Kinase-like domain TRIB1 contains a Ser/Thr kinase-like domain that is composed of some of the motifs present in catalytically active kinases such as a Lysine crucial for ATP binding whilst others are missing. Despite this evidence would suggest TRIB1 no to possess kinase activity. However this domain is highly conserved during evolution suggesting it is important for the role of TRIB1(Hegedus, et al 2007).
C-Terminal Domain The CT domain is around 35-45 amino acids long and is rich in charged amino acids important for protein interactions. Two important motifs have been identified in the CT domain; a hexapeptide motif [D/E]QXVP[D/E] as a COP1 (E3 ubiqutin ligase) binding site, essential for proteasome mediated degradation of C/EBPα family members and a MEK 1 binding site (ILLHPWF) (Hegedus, et al 2007).
Post translational modifications Several post translational modifications of TRIB1 have been reported and validated by mass spectrometry and listed in the PhosphoSitePlus database (Hornbeck, et al 2012).
Expression TRIB1 expression is ubiquitious with highest expression in the thyroid and myeloid cells (Figure?). TRIB1 is thought to expressed in a cell-type specific manner (Sung, et al 2006).
 
  The tissue specific expression of human TRIB1 mRNA is shown. Data and figure taken from BioGPS. Additional microarray expression data from the Human Gene Expression Atlas from the Genomics Institute of the Novartis Research Foundation (GNF) can be found on the UCSC browser ( http://genome.ucsc.edu/) (Su, et al 2004, Wu, et al 2009).
Localisation Numerous over-expression experiments have shown TRIB1 to be located in the nucleus. It contains a putative nuclear localisation signal (Yokoyama, et al 2010).
 
Function TRIB1 has been shown to interact with a number of proteins as detailed herein (Table1):
MEK-1 and MKK4 Co-immunoprecipitation experiments have shown specific interactions with MEK1 (an ERK activator MAPKK) and MKK4 (a JNK activator MAPKK). Interactions with Tribbles control the extent and specificity of MAPK activation and are dependent on levels of TRIB expression (Kiss-Toth, et al 2004, Sung, et al 2007).
MEK1 phosphorylates ERK which in turn promotes cell proliferation and suppression of apoptosis. The interaction between TRIB1 (via ILLHPWF motif) and MEK1
enhances ERK phosphorylation as mutants lacking the motif were unable to do so (Yokoyama, et al 2010) .
TRIB1 also interacts with MKK4, a JNK activator and implicated in the migration and proliferation of smooth muscle and involved in the pathogenesis of atherosclerosis. The nuclear localisation of TRIB1-MKK4 complex is dependent on the NT domain of TRIB1, however the central kinase-like domain of TRIB1 is sufficient for its interaction with MKK4 but the interaction is no longer preferentially nuclear (Sung, et al 2007).
COP1 AND C/EBPalpha TRIB1 contains a COP1 binding site at the carboxy terminus. COP1 is an E3 ubiquitin ligase that promotes the transfer of ubiquitin to target substrates for degradation via the proteasome. One of the prinicipal targets of COP1 are the family of transcription proteins CCAT/enhancer binding proteins (C/EBPs). It is thought TRIB1 acts to negatively regulate C/EBP proteins by acting as adaptors to recruit COP1 to C/EBP family members thereby promoting ubiquitination and degradation. Studies have shown that COP1 requires TRIB1 for its action of α (Yoshida, et al 2013).
Homology TRIB1 homologues have been indentified in different species including mouse, frog and zebrafish. Table 2 illustrates some of the TRIB1 homologues.
 
  Table 2: % protein and DNA identity of human TRIB1 vs other species. Data taken from Homologene and NCBI.

Mutations

Note A somatic point mutation of TRIB1 has been reported in Down syndrome (DS)- related acute megakaryocytic leukaemia (AMKL) (Yokoyama, et al 2012). A G:T point mutation was found in the pseudokinase domain resulting in an amino acid change from arginine to leucine (R107L). When the mutation was expressed in mouse bone marrow cells and transferred into lethally irradiated recipient mice there was a more rapid development of AML and enhancement of ERK phosporylation suggesting a gain of function mutation. Yokoyama, et al (2012) suggests that the mutation of TRIB1 is an early event in leukaemogenesis.
A wide range of allelic variants of TRIB1 have been reported. There are several genetic and protein variations of TRIB1 listed on Ensembl.
Table (3) shows the types of genetic variation of TRIB1. Data taken from: http://Feb2014.archive.ensembl.org/Homo_sapiens/Gene/Variation_Gene/Table?db=core;g=ENSG00000173334;r=8:126442563-126450647
Protein variants of TRIB1: Table 4 shows the protein variants of TRIB1. Each variant is listed in order according to residue number. The table also lists SIFT and Poly-Phen scores for the variations. SIFT predicts whether an amino acid substitution is likely to affect protein function based on the sequence homology and the physico-chemical similarity between the alternate amino acids. Each variant is accompanied with a score and predictive consequence that is based on the probability that the amino acid change is tolerable. A score closer to 0 is more likely to be deleterious. A score of <0.05 are deleterious and all others are tolerated'. PolyPhen predicts the effect of an amino acid substitution on the structure and function of a protein using sequence homology. A PolyPhen score represent the probability that a substitution is damaging, scores nearer to 1 are more confidently to be predicted to be deleterious (opposite to SIFT score). Each score is colour coded according to damage (SIFT; Red= deleterious, Green= tolerated. PolyPhen; Red= probably damaging, Orange= possibly damaging, Green= benign) (Adzhubei, et al 2010, Gonzalez-Perez and Lopez-Bigas 2011, Kumar, et al 2009). Data taken from: http://Feb2014.archive.ensembl.org/Homo_sapiens/Transcript/ProtVariations?db=core;g=ENSG00000173334;r=8:126442563-126450647;t=ENST00000311922
 
  Table 3: Genetic variations of TRIB1
Somatic [Table 4: Protein variants of TRIB1]

Implicated in

  
Entity Smooth muscle cells
Note TRIB1 is selectively over-expressed in chronically inflamed human atherosclerotic arteries and regulates vascular smooth muscle cell (VSMC) chemotaxis and proliferation, a characteristic feature of atherosclerosis via the JNK pathway (Sung, et al 2007).
  
  
Entity Macrophages
Note Trib1 is expressed in plaque resident macrophages in murine experimental atherosclerosis. The expression of Trib1 could be upregulated by IL-1, a major contributor to plaque development as the percentage of Trib1 expressing macrophages significantly decreases in ApoE -/- IL1R-/- double knockout mice compared to ApoE-/- controls. Overexpression of Trib1 in macrophages in vitro also leads to a significant attenuation (~70%) of IL-6 production and suppressed IL-12 expression induced with a pro-inflammatory stimulus (Sung, et al 2012).
It has also been shown that TRIB1 is involved in macrophage migration through interactions with C/EBP β and TNF- α. Knockdown of TRIB1 in RAW246.7 cells resulted in an increase in TNF- α production and C/EBPβ expression suggesting TRIB1 may modulate TNF- α through C/EBP β (Liu, et al 2013).
Trib1 has been shown to also be involved with adipose tissue maintenance and suppression of metabolic disorders by controlling the differentiation of tissue M2-like macrophages. Trib1 deficiency results in a significant reduction of M2-like macrophages. Mice lacking Trib1 in haematopoietic cells show a reduced adipocyte tissue mass and have evidence of increased lipolysis even on a normal diet. Supplementation of M2-like macrophages causes rescue suggesting the lack of these M2-like macrophages are responsible for lipolysis. When mice are fed a high fat diet, mice lacking Trib1 in haematopoietic cells develop hypertriglyceridaemia and insulin resistance and a pro-inflammatory cytokine induction (Satoh, et al 2013).
  
  
Entity Cancer
Note TRIB1 has been associated with the development of cancer and is considered as a leukaemia disease gene. It was identified as a collaborator of Hoxa9 and Meis1 in myeloid leukaemogenesis (Jin, et al 2007). Cooperative genes for Hoxa9/Meis1 were identified as common targets for retroviral integration, where TRIB1 was identified as the most frequent common site for integration in AML (Nakamura 2005). Table 5 shows the common integration sites and candidate cooperative genes in TRIB1-induced AML (Yokoyama and Nakamura 2011). TRIB1 alone is a transforming gene for myeloid cells and also significantly accelerates the development of Hoxa9/Meis1 AML.
 
Table 5: Common integration sites and candidate cooperative genes in TRIB1-induced AML.
Oncogenesis Phosphorylation of ERK is enhanced in TRIB1 transfected HeLa and Baf3 cells and leukaemia cells derived from TRIB1-induced AML upon cytokine stimulation (Jin, et al 2007).
MEK1 and enhancement of MEK/ERK phosporylation is required for reactivity. Mutant lacking MEK1 binding site is unable to enhance phosphorylation of ERK or extend self renewal in bone marrow cells or induce AML/accelerate Hoxa9/Meis1 induced AML (Yokoyama, et al 2010).
TRB1 has been implicated in human AML. TRIB1 is found on chromosome 8q24, 1.5Mb away from c-MYC, the target of AML amplification. TRIB1 is over-expressed even in some cases of AML when c-MYC amplification is not detected (Roethlisberger, et al 2007, Storlazzi, et al 2006)
  
  
Entity Cardiovascular Disease and Atherosclerosis
Note Emerging evidence from several genome-wide association studies (GWAS) has implicated TRIB1 in the risk of cardiovascular disease and events specifically due to the levels of circulating lipids (Kathiresan, et al 2008, Willer, et al 2008).
Two SNPs (rs2954029 and rs17321515) near the TRIB1 gene have been implicated with triglyceride, LDL and HDL levels. A minor G allele at rs17321515 was associated with lower triglyceride and LDL cholesterol and higher HDL cholesterol levels. A TT -> TA -> AA genotypes at rs2954029 were associated with step wise increases in the levels of triglyceride, remnant cholesterol and apo-lipoprotein B, the primary apolipoproteins present on LDLs. Likewise HDL cholesterol levels decreased step-wise through the genotypes. Additionally the genotypes were found to be significantly associated with increased risk of ischemic heart disease (IHD) and increased risk of MI
Further bivariate analysis showed TRIB1 expression to be significantly associated with triglyceride/ elevated blood pressure and triglyceride/HDL-cholesterol suggesting TRIB1 may be involved in a specific feature of lipid homeostasis (Kraja, et al 2011).
These genetic studies were further validated in in vivo models. Specific hepatic over-expression of Trib1 using an adenovirus vector reduced lipid plasma levels in a dose-dependent manner due to reduced VLDL production. Equally the opposite was seen in Trib1- knockout mice due to increased VLDL production. Interestingly when hepatic expression was reconstituted in knockout mice, VLDL-triglyceride production decreased to levels found in control mice (Burkhardt, et al 2010). The precise mechanisms of Trib1 involvement in lipid metabolism however are unknown.
Burkhardt, et al (2010) further investigated by examining the mRNA levels of genes associated with lipid metabolism in the livers of Trib1 over-expressing and Trib1- deficient mice. A significant decrease was found for genes involved in fatty acid oxidation such as Cpt1a (carnitine palmitoyltransferase 1A), Cpt2, and Acox1 (acyl-Coenzyme A oxidase 1) in Trib1 -/- mice. A significant up-regulation of key lipogeneic genes was also found such as Acc1 (acetyl-Coenzyme A carboxylase), fatty acid synthesis (Fasn) and stearoyl-Coenzyme A desaturase 1(Scd1). Significant downregulation of these genes were found in Trib1-over expressing mice. These genes have been noted to have effects on VLDL secretion and plasma triglyceride and cholesterol levels.
TRIB1 may also have a further role in lipogenesis. TRIB1 over-expression resulted in a significant decrease in 35S-methionine labelled apoB secretion in HepG2 cells (human liver carcinoma cell line). The authors speculate that TRIB1-mediated regulation of hepatic lipid availability might alter the secretion of apoB particles via a mechanism involving ER-associated degradation (ERAD) as previous data has shown a reduced availability or synthesis of lipid for apoB lipidation leads to co-translational targeting of apoB for ERAD (Ginsberg, et al 2009).
  
  
Entity Type 2 Diabetes
Note Trib1 has been hypothesised to have a regulatory role in inflammation in adipoctyes that may contribute towards obesity related type 2 diabetes. Trib1 is specifically up-regulated during acute and chronic inflammation in white adipose tissue in mice. Trib1 knockout mice show it to be a key regulator of inflammatory cytokines such as TNF-a and are protected from high fat diet induced obesity (Ostertag, et al 2010). It is proposed that Trib1 is pro-inflammatory in the adipose by acting as a co-activator for NF-kB inducing the expression of proinflammatory cytokines.
  

Bibliography

 
A method and server for predicting damaging missense mutations
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR
Nat Methods 2010 Apr;7(4):248-9
PMID 20354512
 
Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn MA, Cantley LC, Gygi SP
Proc Natl Acad Sci U S A 2004 Aug 17;101(33):12130-5
PMID 15302935
 
Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice
Burkhardt R, Toh SA, Lagor WR, Birkeland A, Levin M, Li X, Robblee M, Fedorov VD, Yamamoto M, Satoh T, Akira S, Kathiresan S, Breslow JL, Rader DJ
J Clin Invest 2010 Dec;120(12):4410-4
PMID 21084752
 
Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol
Edmondson AC, Braund PS, Stylianou IM, Khera AV, Nelson CP, Wolfe ML, Derohannessian SL, Keating BJ, Qu L, He J, Tobin MD, Tomaszewski M, Baumert J, Klopp N, Döring A, Thorand B, Li M, Reilly MP, Koenig W, Samani NJ, Rader DJ
Circ Cardiovasc Genet 2011 Apr;4(2):145-55
PMID 21303902
 
Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel
González-Pérez A, López-Bigas N
Am J Hum Genet 2011 Apr 8;88(4):440-9
PMID 21457909
 
A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila
Grosshans J, Wieschaus E
Cell 2000 May 26;101(5):523-31
PMID 10850494
 
Tribbles: a family of kinase-like proteins with potent signalling regulatory function
Hegedus Z, Czibula A, Kiss-Toth E
Cell Signal 2007 Feb;19(2):238-50
PMID 16963228
 
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Jin G, Yamazaki Y, Takuwa M, Takahara T, Kaneko K, Kuwata T, Miyata S, Nakamura T
Blood 2007 May 1;109(9):3998-4005
PMID 17227832
 
Functional selectivity of recombinant mammalian SWI/SNF subunits
Kadam S, McAlpine GS, Phelan ML, Kingston RE, Jones KA, Emerson BM
Genes Dev 2000 Oct 1;14(19):2441-51
PMID 11018012
 
Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia
Keeshan K, He Y, Wouters BJ, Shestova O, Xu L, Sai H, Rodriguez CG, Maillard I, Tobias JW, Valk P, Carroll M, Aster JC, Delwel R, Pear WS
Cancer Cell 2006 Nov;10(5):401-11
PMID 17097562
 
Human tribbles, a protein family controlling mitogen-activated protein kinase cascades
Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, Caunt JC, Oxley KM, Wyllie DH, Polgar T, Harte M, O'neill LA, Qwarnstrom EE, Dower SK
J Biol Chem 2004 Oct 8;279(41):42703-8
PMID 15299019
 
A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium
Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, Sovio U, Mathias RA, Sun YV, Franceschini N, Absher D, Li G, Zhang Q, Feitosa MF, Glazer NL, Haritunians T, Hartikainen AL, Knowles JW, North KE, Iribarren C, Kral B, Yanek L, O'Reilly PF, McCarthy MI, Jaquish C, Couper DJ, Chakravarti A, Psaty BM, Becker LC, Province MA, Boerwinkle E, Quertermous T, Palotie L, Jarvelin MR, Becker DM, Kardia SL, Rotter JI, Chen YD, Borecki IB
Diabetes 2011 Apr;60(4):1329-39
PMID 21386085
 
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Kumar P, Henikoff S, Ng PC
Nat Protoc 2009;4(7):1073-81
PMID 19561590
 
Macrophage migration is controlled by Tribbles 1 through the interaction between C/EBPβ and TNF-α
Liu YH, Tan KA, Morrison IW, Lamb JR, Argyle DJ
Vet Immunol Immunopathol 2013 Sep 1;155(1-2):67-75
PMID 23810419
 
Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis
Mata J, Curado S, Ephrussi A, Rørth P
Cell 2000 May 26;101(5):511-22
PMID 10850493
 
VectorBase: improvements to a bioinformatics resource for invertebrate vector genomics
Megy K, Emrich SJ, Lawson D, Campbell D, Dialynas E, Hughes DS, Koscielny G, Louis C, Maccallum RM, Redmond SN, Sheehan A, Topalis P, Wilson D; VectorBase Consortium
Nucleic Acids Res 2012 Jan;40(Database issue):D729-34
PMID 22135296
 
TRB2, a mouse Tribbles ortholog, suppresses adipocyte differentiation by inhibiting AKT and C/EBPbeta
Naiki T, Saijou E, Miyaoka Y, Sekine K, Miyajima A
J Biol Chem 2007 Aug 17;282(33):24075-82
PMID 17576771
 
Control of adipose tissue inflammation through TRB1
Ostertag A, Jones A, Rose AJ, Liebert M, Kleinsorg S, Reimann A, Vegiopoulos A, Berriel Diaz M, Strzoda D, Yamamoto M, Satoh T, Akira S, Herzig S
Diabetes 2010 Aug;59(8):1991-2000
PMID 20522600
 
TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism
Qi L, Heredia JE, Altarejos JY, Screaton R, Goebel N, Niessen S, Macleod IX, Liew CW, Kulkarni RN, Bain J, Newgard C, Nelson M, Evans RM, Yates J, Montminy M
Science 2006 Jun 23;312(5781):1763-6
PMID 16794074
 
FancyGene: dynamic visualization of gene structures and protein domain architectures on genomic loci
Rambaldi D, Ciccarelli FD
Bioinformatics 2009 Sep 1;25(17):2281-2
PMID 19542150
 
Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages
Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, Yoshioka Y, Morii E, Takakura N, Takeuchi O, Akira S
Nature 2013 Mar 28;495(7442):524-8
PMID 23515163
 
MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene
Storlazzi CT, Fioretos T, Surace C, Lonoce A, Mastrorilli A, Strömbeck B, D'Addabbo P, Iacovelli F, Minervini C, Aventin A, Dastugue N, Fonatsch C, Hagemeijer A, Jotterand M, Mühlematter D, Lafage-Pochitaloff M, Nguyen-Khac F, Schoch C, Slovak ML, Smith A, Solè F, Van Roy N, Johansson B, Rocchi M
Hum Mol Genet 2006 Mar 15;15(6):933-42
PMID 16452126
 
A gene atlas of the mouse and human protein-encoding transcriptomes
Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB
Proc Natl Acad Sci U S A 2004 Apr 20;101(16):6062-7
PMID 15075390
 
Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific
Sung HY, Francis SE, Crossman DC, Kiss-Toth E
Immunol Lett 2006 Apr 15;104(1-2):171-7
PMID 16364454
 
Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways
Sung HY, Guan H, Czibula A, King AR, Eder K, Heath E, Suvarna SK, Dower SK, Wilson AG, Francis SE, Crossman DC, Kiss-Toth E
J Biol Chem 2007 Jun 22;282(25):18379-87
PMID 17452330
 
The use of anabolic steroids in high school students
Terney R, McLain LG
Am J Dis Child 1990 Jan;144(1):99-103
PMID 2294728
 
TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population
Varbo A, Benn M, Tybjærg-Hansen A, Grande P, Nordestgaard BG
Arterioscler Thromb Vasc Biol 2011 Feb;31(2):451-7
PMID 21071687
 
BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW 3rd, Su AI
Genome Biol 2009;10(11):R130
PMID 19919682
 
Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation
Yokoyama T, Nakamura T
Cancer Sci 2011 Jun;102(6):1115-22
PMID 21338441
 
COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1
Yoshida A, Kato JY, Nakamae I, Yoneda-Kato N
Blood 2013 Sep 5;122(10):1750-60
PMID 23884858
 

Citation

This paper should be referenced as such :
Johnston J, Kiss-Toth E
Atlas Genet Cytogenet Oncol Haematol. in press
On line version : http://AtlasGeneticsOncology.org/Genes/TRIB1ID43539ch8q24.html


Other Leukemias implicated (Data extracted from papers in the Atlas) [ 1 ]
  r(8)


External links

Nomenclature
HGNC (Hugo)TRIB1   16891
Cards
AtlasTRIB1ID43539ch8q24
Entrez_Gene (NCBI)TRIB1  10221  tribbles pseudokinase 1
AliasesC8FW; GIG-2; GIG2; SKIP1; 
TRB-1; TRB1
GeneCards (Weizmann)TRIB1
Ensembl hg19 (Hinxton)ENSG00000173334 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000173334 [Gene_View]  chr8:125432209-125438405 [Contig_View]  TRIB1 [Vega]
ICGC DataPortalENSG00000173334
TCGA cBioPortalTRIB1
AceView (NCBI)TRIB1
Genatlas (Paris)TRIB1
WikiGenes10221
SOURCE (Princeton)TRIB1
Genetics Home Reference (NIH)TRIB1
Genomic and cartography
GoldenPath hg38 (UCSC)TRIB1  -     chr8:125432209-125438405 +  8q24.13   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)TRIB1  -     8q24.13   [Description]    (hg19-Feb_2009)
EnsemblTRIB1 - 8q24.13 [CytoView hg19]  TRIB1 - 8q24.13 [CytoView hg38]
Mapping of homologs : NCBITRIB1 [Mapview hg19]  TRIB1 [Mapview hg38]
OMIM609461   
Gene and transcription
Genbank (Entrez)AF205437 AF250310 AJ000480 AK001319 AK022787
RefSeq transcript (Entrez)NM_001282985 NM_025195
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)TRIB1
Cluster EST : UnigeneHs.444947 [ NCBI ]
CGAP (NCI)Hs.444947
Alternative Splicing GalleryENSG00000173334
Gene ExpressionTRIB1 [ NCBI-GEO ]   TRIB1 [ EBI - ARRAY_EXPRESS ]   TRIB1 [ SEEK ]   TRIB1 [ MEM ]
Gene Expression Viewer (FireBrowse)TRIB1 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevisibleExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)10221
GTEX Portal (Tissue expression)TRIB1
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ96RU8   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ96RU8  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ96RU8
Splice isoforms : SwissVarQ96RU8
PhosPhoSitePlusQ96RU8
Domaine pattern : Prosite (Expaxy)PROTEIN_KINASE_DOM (PS50011)   
Domains : Interpro (EBI)Kinase-like_dom    Prot_kinase_dom    TRB1    Tribbles/Ser_Thr_kinase_40   
Domain families : Pfam (Sanger)Pkinase (PF00069)   
Domain families : Pfam (NCBI)pfam00069   
Domain families : Smart (EMBL)S_TKc (SM00220)  
Conserved Domain (NCBI)TRIB1
DMDM Disease mutations10221
Blocks (Seattle)TRIB1
PDB (SRS)5CEK    5CEM    5IGO    5IGQ   
PDB (PDBSum)5CEK    5CEM    5IGO    5IGQ   
PDB (IMB)5CEK    5CEM    5IGO    5IGQ   
PDB (RSDB)5CEK    5CEM    5IGO    5IGQ   
Structural Biology KnowledgeBase5CEK    5CEM    5IGO    5IGQ   
SCOP (Structural Classification of Proteins)5CEK    5CEM    5IGO    5IGQ   
CATH (Classification of proteins structures)5CEK    5CEM    5IGO    5IGQ   
SuperfamilyQ96RU8
Human Protein AtlasENSG00000173334
Peptide AtlasQ96RU8
HPRD09863
IPIIPI00290308   IPI01013113   IPI00797829   
Protein Interaction databases
DIP (DOE-UCLA)Q96RU8
IntAct (EBI)Q96RU8
FunCoupENSG00000173334
BioGRIDTRIB1
STRING (EMBL)TRIB1
ZODIACTRIB1
Ontologies - Pathways
QuickGOQ96RU8
Ontology : AmiGOprotein kinase activity  protein kinase inhibitor activity  protein binding  ATP binding  nucleus  cytoplasm  protein phosphorylation  negative regulation of protein kinase activity  JNK cascade  transcription factor binding  negative regulation of smooth muscle cell migration  mitogen-activated protein kinase kinase binding  ubiquitin protein ligase binding  negative regulation of lipopolysaccharide-mediated signaling pathway  positive regulation of proteasomal ubiquitin-dependent protein catabolic process  positive regulation of proteasomal ubiquitin-dependent protein catabolic process  response to lipopolysaccharide  response to lipopolysaccharide  regulation of MAP kinase activity  negative regulation of sequence-specific DNA binding transcription factor activity  negative regulation of sequence-specific DNA binding transcription factor activity  positive regulation of eosinophil differentiation  positive regulation of macrophage differentiation  negative regulation of neutrophil differentiation  negative regulation of smooth muscle cell proliferation  ubiquitin-protein transferase regulator activity  
Ontology : EGO-EBIprotein kinase activity  protein kinase inhibitor activity  protein binding  ATP binding  nucleus  cytoplasm  protein phosphorylation  negative regulation of protein kinase activity  JNK cascade  transcription factor binding  negative regulation of smooth muscle cell migration  mitogen-activated protein kinase kinase binding  ubiquitin protein ligase binding  negative regulation of lipopolysaccharide-mediated signaling pathway  positive regulation of proteasomal ubiquitin-dependent protein catabolic process  positive regulation of proteasomal ubiquitin-dependent protein catabolic process  response to lipopolysaccharide  response to lipopolysaccharide  regulation of MAP kinase activity  negative regulation of sequence-specific DNA binding transcription factor activity  negative regulation of sequence-specific DNA binding transcription factor activity  positive regulation of eosinophil differentiation  positive regulation of macrophage differentiation  negative regulation of neutrophil differentiation  negative regulation of smooth muscle cell proliferation  ubiquitin-protein transferase regulator activity  
NDEx NetworkTRIB1
Atlas of Cancer Signalling NetworkTRIB1
Wikipedia pathwaysTRIB1
Orthology - Evolution
OrthoDB10221
GeneTree (enSembl)ENSG00000173334
Phylogenetic Trees/Animal Genes : TreeFamTRIB1
HOVERGENQ96RU8
HOGENOMQ96RU8
Homologs : HomoloGeneTRIB1
Homology/Alignments : Family Browser (UCSC)TRIB1
Gene fusions - Rearrangements
Fusion : MitelmanTRIB1/NSMCE2 [8q24.13/8q24.13]  
Fusion : MitelmanTRIB1/SLC25A32 [8q24.13/8q22.3]  [t(8;8)(q22;q24)]  
Fusion: TCGATRIB1 8q24.13 NSMCE2 8q24.13 BRCA LUAD
Fusion: TCGATRIB1 8q24.13 SLC25A32 8q22.3 BRCA
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerTRIB1 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)TRIB1
dbVarTRIB1
ClinVarTRIB1
1000_GenomesTRIB1 
Exome Variant ServerTRIB1
ExAC (Exome Aggregation Consortium)TRIB1 (select the gene name)
Genetic variants : HAPMAP10221
Genomic Variants (DGV)TRIB1 [DGVbeta]
DECIPHERTRIB1 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisTRIB1 
Mutations
ICGC Data PortalTRIB1 
TCGA Data PortalTRIB1 
Broad Tumor PortalTRIB1
OASIS PortalTRIB1 [ Somatic mutations - Copy number]
Mutations and Diseases : HGMDTRIB1
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
BioMutasearch TRIB1
DgiDB (Drug Gene Interaction Database)TRIB1
DoCM (Curated mutations)TRIB1 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)TRIB1 (select a term)
intoGenTRIB1
NCG5 (London)TRIB1
Cancer3DTRIB1(select the gene name)
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM609461   
Orphanet
MedgenTRIB1
Genetic Testing Registry TRIB1
NextProtQ96RU8 [Medical]
TSGene10221
GENETestsTRIB1
Target ValidationTRIB1
Huge Navigator TRIB1 [HugePedia]
snp3D : Map Gene to Disease10221
BioCentury BCIQTRIB1
ClinGenTRIB1
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD10221
Chemical/Pharm GKB GenePA134963922
Clinical trialTRIB1
Miscellaneous
canSAR (ICR)TRIB1 (select the gene name)
Probes
Litterature
PubMed86 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineTRIB1
EVEXTRIB1
GoPubMedTRIB1
iHOPTRIB1
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Aug 8 15:49:27 CEST 2017

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.